Adverse Drug Reaction Classification System

ADR Ontology
ADR Term Schwannoma
ADR ID BADD_A10887
ADR Hierarchy
16      Neoplasms benign, malignant and unspecified (incl cysts and polyps)
16.30      Nervous system neoplasms malignant and unspecified NEC
16.30.01      Nervous system neoplasms unspecified malignancy NEC
16.30.01.013      Schwannoma
17      Nervous system disorders
17.20      Nervous system neoplasms malignant and unspecified NEC
17.20.01      Nervous system neoplasms unspecified malignancy NEC
17.20.01.013      Schwannoma
Description A neoplasm that arises from SCHWANN CELLS of the cranial, peripheral, and autonomic nerves. Clinically, these tumors may present as a cranial neuropathy, abdominal or soft tissue mass, intracranial lesion, or with spinal cord compression. Histologically, these tumors are encapsulated, highly vascular, and composed of a homogenous pattern of biphasic fusiform-shaped cells that may have a palisaded appearance. (From DeVita Jr et al., Cancer: Principles and Practice of Oncology, 5th ed, pp964-5) [MeSH]
MedDRA Code 10039667
MeSH ID D009442
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE) Not Available
Synonym
Neurilemmoma | Neurilemoma | Schwannoma | Neurilemmomas | Schwannomas | Neurilemomas | Neurinoma | Neurinomas | Schwannomatosis, Plexiform | Plexiform Schwannomatoses | Plexiform Schwannomatosis
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D01835Pregabalin0.000052%
The 1th Page    1    Total 1 Pages